{
 "id": "huntington-s-disease",
 "name": "Huntington's Disease",
 "aliases": [],
 "acronyms": [],
 "bodySystem": "neurological",
 "parent": null,
 "children": [],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 0,
  "limited": 0,
  "waitlist": 0,
  "closed": 1
 },
 "funds": [
  {
   "fund": "Huntington's Disease - Medicare Access",
   "organization": "HealthWell Foundation",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://www.healthwellfoundation.org/disease-funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "Valbenazine Tosylate",
   "pages": [
    {
     "brand": "Ingrezza",
     "url": "https://omnirx.org/medicines/ingrezza"
    }
   ],
   "labelSentence": "... chorea associated with Huntington’s disease [see Clinical Studies ( 14.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%224c970164-cafb-421f-9eb5-c226ef0a3417%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Neurocrine Access Support: INGREZZA Patient Assistance Program",
     "url": "https://ingrezza.neurocrineaccesssupport.com/hcp/financial-support-programs/",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "Single-product program page (INGREZZA)",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "DEUTETRABENAZINE",
   "pages": [
    {
     "brand": "Austedo",
     "url": "https://omnirx.org/negotiated-drugs/austedo"
    }
   ],
   "labelSentence": "... chorea associated with Huntington’s disease [see Clinical Studies ( 14.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%227ea3c60a-45c7-44cc-afc2-d87fa53993c0%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": {
    "usd30DaySupply": 4093,
    "effective": "2027-01-01",
    "source": "https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices"
   }
  }
 ],
 "fundsForRelatedCosts": [],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}